Genomunity.com
Genetic Immunity

Genomunity is the application of genetic engineering to the restoration or enhancement of the functioning of the human immune system. Humans have been directly the genetic development of plants and animals for millennia through methods such as selective breeding. However, modern genetic engineering is making novel organisms in a more direct and speedy way. Genetically Modified Organisms (GMOs) will likely produce products - such as biological compound and organic compounds - in larger, and more pure, volumes than possible before. Many investigators believe that genetic engineering will bring important advances in numerous areas in the years to come. It is already starting to recreate the disciplines of agriculture and medicine. However, thus far most biomedicine firms demand several years before achieving profitability and thus investment in biotechnology has serious risk as well as considerable promise. The characteristics of a living organism and its offspring will likely be altered by modifying selected portions of its genetic composite. In many organisms (with some exceptions such as viruses), this genetic substance is based on DNA molecules that preserve and convey genetic data through successive generations. The DNA of unique species of biological organisms will likely be cut and recombined to construct original organisms with ground-breaking genetic codes and elements. The whose of the genetic material for an organism is its "genome." Genomunity: (n.) ge-no-moo'-ne-tee 1. Genetically inherited state of resistance to a specific pathogen. 2. State of resistance to a specific pathogen acquired or induced through commercialization of genomic science. fr. German: Genom + Latin: Immunis. Rapid advances in genomic science, and their practical usage in the biomedicine sector, are enabling the construction of current biologic agents, tissue and tissues. These advances will generally support to: prevent and cure illness; perform physiological functions; and upgrade life. These biotechnological advances have the capability to supplant medical machines and, in the future, total tissues by: producing substances needed by the body (such as insulin to control diabetes or dopamine to control Parkinson's disease) that are lacking due to malady, genetic abnormality, or injury; performing physiological or structural functions (such as filtration as an artificial kidney, oxygen exchange as a fabricated lung, or connectivity as a simulated tendon) that have been impaired by illness, genetic abnormality, or injury; or providing immunity (such as resistance to cancer or viruses). Click images below for more information on biotech and neurotech T-shirts: Questions and suggestions concerning the site Genomunity.com may be sent to: Genomunity.com © 2006 by Genomunity.com